AHMED NADIM 4
4 · Cullinan Oncology, Inc. · Filed Feb 23, 2023
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-02-22+109,000→ 118,710 total - Award
Stock Option (Right to Buy)
2023-02-22+211,000→ 211,000 totalExercise: $11.03Exp: 2033-02-21→ Common Stock (211,000 underlying)
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.